Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Executive Insights Life Sciences & Pharma Quantum Computing in Biopharma: Future Prospects and Strategic Insights May 1, 2025
Video / Webinar Healthcare Services Australia's Clinical Trials: Innovation and Growth February 24, 2025
Executive Insights Life Sciences & Pharma Redefining Biopharma R&D Productivity: New Insights and Strategies January 9, 2025
Published Articles Life Sciences & Pharma A Strategic Framework for Evaluating AI in Drug Discovery December 6, 2024
Case Study Biotech and Pharmaceuticals Supporting an Emerging Biopharma To Build Out AI With Confidence October 22, 2024